本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Apogee Therapeutics

47.46
+3.147.08%
盘后47.500.0400+0.08%16:20 EDT
成交量:50.68万
成交额:2,350.73万
市值:27.70亿
市盈率:-13.22
高:47.71
开:44.71
低:43.51
收:44.32
数据加载中...
2025/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/21

重要事件披露

Form 8-K - Current report
2025/05/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/12

重要事件披露

Form 8-K - Current report
2025/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/11

重要事件披露

Form 8-K - Current report
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

重要事件披露

Form 8-K - Current report
2025/03/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/03

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

重要事件披露

Form 8-K - Current report
2025/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

重要事件披露

Form 8-K - Current report
2024/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]